Digital cognitive assessment and eCOA platform
CANTAB sensitively and objectively measures cognitive function, quantifies levels of performance and impairment, and demonstrates the effectiveness of interventions in brain health. The cloud technology enables efficient, non-invasive means of assaying brain function and participant outcomes, improving clinical trials and accelerating decision-making.
Originally developed at the University of Cambridge, the Cambridge Neuropsychological Test Automated Battery (CANTAB) includes highly sensitive, precise, and objective measures of cognitive function, correlated to neural networks.
CANTAB tests have demonstrated sensitivity to detecting changes in neuropsychological performance and include tests of working memory, learning and executive function; visual, verbal and episodic memory; attention, information processing and reaction time; social and emotion recognition, decision making and response control.
The tests show high sensitivity to positive and negative pharmacological, genetic and environmental effects in healthy individuals and patient populations across all areas of research.
CANTAB is language-independent, culturally neutral, non-invasive and require no technical knowledge or prior familiarity with computers making them suitable for large, multi-site studies and diverse participant groups.